Sen. Patty Murray (D-Wash.) on Oct. 26 proposed an amendment to the Labor-HHS appropriations bill (HR 3010) that would have mandated an investigation into alleged mismanagement at FDA -- including the agency's handling of a proposal to make the emergency contraceptive Plan B available without a prescription -- but later withdrew the amendment because Sen. Tom Coburn (R-Okla.) would have introduced an amendment calling for an investigation into the agency's approval of mifepristone, FDA Week reports (FDA Week, 11/4).
That Patty Murray would back down from an investigation into the approval of mifepristone tells you all you need to know about its safety. However, Senator Coburn is really on to something. We do need to have an investigation into how the FDA approved mifepristone under a set of FDA rules known as subpart H, which usually is reserved for approving drugs for life-threatening illnesses.
How did a drug that kills get approved under the pretext of saving lives? It's probably news to Patty Murray that pregnancy is not a life-threatening illness but the FDA should have known better. That's not medicine, that's ideology.
No comments:
Post a Comment